972 results on '"Familial Hypophosphatemic Rickets"'
Search Results
2. Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
3. Expanded Access to Burosumab
4. Registry for Patients With X-Linked Hypophosphatemia
5. Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency
6. A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal Growth
7. ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
8. Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH
9. Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners (SUNFLOWER)
10. A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH
11. Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH
12. Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH
13. The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency
14. The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency (ENERGY)
15. An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
16. A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
17. Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
18. Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
19. A Study of KRN23 in X-linked Hypophosphatemia
20. X-linked Hypophosphatemia Disease Monitoring Program
21. Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency
22. Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
23. Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
24. Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
25. Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
26. Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
27. Baby Detect : Genomic Newborn Screening
28. Early Check: Expanded Screening in Newborns
29. Calcitriol Monotherapy for X-Linked Hypophosphatemia
30. Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLH (FLAM-XLH)
31. Burden of Disease and Functional Impairment in XLH (IdeFIX)
32. Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy Controls
33. Retrospective and Prospective Disease Progression and Quality of Life in XLH
34. Foot Disorders in X-linked Hypophosphatemia
35. National Registry of Rare Kidney Diseases (RaDaR)
36. Examining the Effect of Burosumab on Muscle Function
37. Anti-FGF23 (Burosumab) in Adult Patients With XLH (BurGER)
38. Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts (HYPO-CLASTE)
39. A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia
40. A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia
41. FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) (GAP)
42. Dental Implants in Patients With X-linked Hypophosphatemia (IMPLANTS-XLH)
43. Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH
44. Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT (PRADEX)
45. Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency
46. Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
47. Calcimimetics in Hypophosphatemic Rickets (CHR)
48. X-linked Hypophosphatemia and FGF21 (XLH 21)
49. Burosumab in Children and Adolescents With X-linked Hypophosphatemia
50. Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.